Target profile prediction and practical evaluation of a biginelli-type dihydropyrimidine compound library

Pharmaceuticals

Volumn 4, Issue 9, 2011, Pages 1236-1247

  Schneider, Petra ^a   Stutz, Katharina ^a   Kasper, Ladina ^a   Haller, Sarah ^a   Reutlinger, Michael ^a   Reisen, Felix ^a   Geppert, Tim ^a   Schneider, Gisbert ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Combinatorial chemistry; Drug design; In silico pharmacology; Kinase inhibitor; Multi component reaction; Self organizing map

Indexed keywords

CYCLIN DEPENDENT KINASE 2; DIHYDROPYRIMIDINE; PYRIMIDINE; UNCLASSIFIED DRUG;

ACCURACY; ALGORITHM; ANALYTIC METHOD; ARTICLE; BIGINELLI REACTION; BIOLOGICAL ACTIVITY; CHEMICAL STRUCTURE; COMBINATORIAL CHEMISTRY; COMBINATORIAL LIBRARY; COMPUTER MODEL; CONTROLLED STUDY; DRUG DESIGN; ENZYME ASSAY; EVALUATION RESEARCH; IN VITRO STUDY; MACROMOLECULE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; PREDICTION; VIRTUAL REALITY;

EID: 80053588208     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph4091236     Document Type: Article

References (56)

1. Foloppe, N. The benefits of constructing leads from fragment hits. Future Med. Chem. 2011, 3, 1111-1115.
2. Hartenfeller, M.; Schneider, G. Enabling future drug discovery by de novo design. Comp. Mol. Sci. 2011, 1, 742-759.
3. Rognan, D. Fragment-based approaches and computer-aided drug discovery. Top. Curr. Chem. 2011, in press.
4. Vinkers, H.M.; de Jonge, M.R.; Daeyaert, F.F.; Heeres, J.; Koymans, L.M.; van Lenthe, J.H.; Lewi, P.J.; Timmerman, H.; van Aken, K.; Janssen, P.A. Synopsis: Synthesize and optimize system in silico. J. Med. Chem. 2003, 46, 2765-2773.
5. Schneider, G.; Geppert, T.; Hartenfeller, M.; Reisen, F.; Klenner, A.; Reutlinger, M.; Hähnke, V.; Hiss, J.A.; Zettl, H.; Keppner, S.; et al. Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors. Future Med. Chem. 2011, 3, 415-424.
6. Weber, L. The application of multi-component reactions in drug discovery. Curr. Med. Chem. 2002, 9, 2085-2093.
7. Dandapani, S.; Marcaurelle, L.A. Current strategies for diversity-oriented synthesis. Curr. Opin. Chem. Biol. 2010, 14, 362-370.
8. Schüller, A.; Fechner, U.; Renner, S.; Franke, L.; Weber, L.; Schneider, G. A pseudo-ligand approach to virtual screening. Comb. Chem. High Throughput Screen. 2006, 9, 359-364.
9. Weber, L.; Wallbaum, S.; Broger, C.; Gubernator, K. Optimization of the biological activity of combinatorial compound libraries by a genetic algorithm. Angew. Chem. Int. Ed. 1995, 34, 2280-2282.
10. Schneider, G.; Fechner, U. Computer-based de novo design of drug-like molecules. Nat. Rev. Drug Discov. 2005, 4, 649-663.
11. Zaliani, A.; Boda, K.; Seidel, T.; Herwig, A.; Schwab, C.H.; Gasteiger, J.; Claußen, H.; Lemmen, C.; Degen, J.; Pärn, J.; et al. Second-generation de novo design: A view from a medicinal chemist perspective. J. Comput. Aided Mol. Des. 2009, 23, 593-602.
12. Biginelli, P. Ueber aldehyduramide des acetessigäthers. Ber. Dtsch. Chem. Ges. 1891, 24, 1317-1319.
13. Kappe, C.O. The Biginelli reaction. ChemInform 2007, 38, 95-120.
14. Kohonen, T. Self-organized formation of topologically correct feature maps. Biol. Cybern. 1982, 43, 59-69.
15. Schneider, G. Trends in virtual combinatorial library design. Curr. Med. Chem. 2002, 9, 2095-2101.
16. Lee, M.L.; Schneider, G. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: Application in the design of natural product-based combinatorial libraries. J. Comb. Chem. 2001, 3, 284-289.
17. Yan, A. Application of self-organizing maps in compounds pattern recognition and combinatorial library design. Comb. Chem. High Throughput Screen. 2006, 9, 473-480.
18. Noeske, T.; Sasse, B.C.; Stark, H.; Parsons, C.G.; Weil, T.; Schneider, G. Predicting compound selectivity by self-organizing maps: Cross-activities of metabotropic glutamate receptor antagonists. ChemMedChem 2006, 1, 1066-1068.
19. Schneider, G.; Tanrikulu, Y.; Schneider, P. Self-organizing molecular fingerprints: A ligand-based view on drug-like chemical space and off-target prediction. Future Med. Chem. 2009, 1, 213-218.
20. Schneider, P.; Tanrikulu, Y.; Schneider, G. Self-organizing maps in drug discovery: Compound library design, scaffold-hopping, repurposing. Curr. Med. Chem. 2009, 16, 258-266.
21. Oprea, T.I.; Nielsen, S.K.; Ursu, O.; Yang, J.J.; Taboureau, O.; Mathias, S.L.; Kouskoumvekaki, I.; Sklar, L.A.; Bologa, C.G. Associating drugs, targets and clinical outcomes into an integrated network affords a new platform for computer-aided repurposing. Mol. Inf. 2011, 30, 100-111.
22. Garcia-Serna, R.; Mestres, J. Anticipating drug side effects by comparative pharmacology. Expert Opin. Drug Metab. Toxicol. 2010, 6, 1253-1263.
23. Vidal, D.; Garcia-Serna, R.; Mestres, J. Ligand-based approaches to in silico pharmacology. Methods Mol. Biol. 2011, 672, 489-502.
24. Digles, D.; Ecker, G. Self-organizing maps for in silico screening and data visualization. Mol. Inform. 2011, 30, doi:10.1002/minf.201100082.
25. Schneider, G.; Neidhart, W.; Giller, T.; Schmid, G. 'Scaffold-hopping' by topological pharmacophore search: A contribution to virtual screening. Angew. Chem. Int. Ed. 1999, 38, 2894-2896.
26. Reisen, F.H.; Schneider, G.; Proschak, E. Reaction-MQL: Line notation for functional transformation. J. Chem. Inf. Model. 2009, 49, 6-12.
27. Fechner, U.; Franke, L.; Renner, S.; Schneider, P.; Schneider, G. Comparison of correlation vector methods for ligand-based similarity searching. J. Comput. Aided Mol. Des. 2003, 17, 687-698.
28. Fechner, U.; Schneider, G. Optimization of a pharmacophore-based correlation vector descriptor for similarity searching. QSAR Comb. Sci. 2004, 23, 19-22.
29. Schneider, P.; Schneider, G. Collection of bioactive reference compounds for focused library design. QSAR Comb. Sci. 2003, 22, 713-718.
30. Schneider, G.; Schneider, P. Navigation in Chemical Space: Ligand-Based Design of Focused Compound Libraries. In Chemogenomics in Drug Discovery; Kubinyi, H., Müller, G., Eds.; Wiley-VCH: Weinheim, Germany, 2004; pp. 341-376.
31. Kappe, C.O.; Dallinger, D. The impact of microwave synthesis on drug discovery. Nat. Rev. Drug Discov. 2006, 5, 51-63.
32. Kürti, L., Czakó, B. Strategic Applications of Named Reactions in Organic Synthesis; Elsevier Academic Press: Amsterdam, The Netherlands, 2005; pp. 58-59, 330-331.
33. Stadler, A.; Kappe, C.O. Automated library generation using sequential microwave-assisted chemistry. Application toward the Biginelli multicomponent condensation. J. Comb. Chem. 2001, 3, 624-630.
34. Schneider, G.; Nettekoven, M. Ligand-based combinatorial design of selective purinergic receptor (A2A) antagonists using self-organizing maps. J. Comb. Chem. 2003, 5, 233-237.
35. Schneider, G.; Hartenfeller, M.; Reutlinger, M.; Tanrikulu, Y.; Proschak, E.; Schneider, P. Voyages to the (un)known: Adaptive design of bioactive compounds. Trends Biotechnol. 2009, 27, 18-26.
36. Bramson, H.N.; Corona, J.; Davis, S.T.; Dickerson, S.H.; Edelstein, M.; Frye, S.V.; Gampe, R.T., Jr.; Harris, P.A.; Hassell, A.; Holmes, W.D.; et al. Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): Design, synthesis, enzymatic activities, and X-ray crystallographic analysis. J. Med. Chem. 2001, 44, 4339-4358.
37. Schneider, G.; Clément-Chomienne, O.; Hilfiger, L.; Schneider, P.; Kirsch, S.; Böhm, H.J.; Neidhart, W. Virtual screening for bioactive molecules by evolutionary de novo design. Angew. Chem. Int. Ed. 2000, 39, 4130-4133.
38. Langdon, S.R.; Ertl, P.; Brown, N. Bioisosteric replacement and scaffold hopping in lead generation and optimization. Mol. Inform. 2010, 29, 366-385.
39. Klenner, A.; Hartenfeller, M.; Schneider, P.; Schneider, G. 'Fuzziness' in pharmacophore-based virtual screening and de novo design. Drug Discov. Today Technol. 2010, 7, e237-e244.
40. Willett, P. Similarity searching using 2D structural fingerprints. Methods Mol. Biol. 2011, 672, 133-158.
41. Hert, J.; Willett, P.; Wilton, D.J.; Acklin, P.; Azzaoui, K.; Jacoby, E.; Schuffenhauer, A. New methods for ligand-based virtual screening: Use of data fusion and machine learning to enhance the effectiveness of similarity searching. J. Chem. Inf. Model. 2006, 46, 462-470.
42. Holliday, J.D.; Kanoulas, E.; Malim, N.; Willett, P. Multiple search methods for similarity-based virtual screening: Analysis of search overlap and precision. J. Cheminform. 2011, 3, 29.
43. Selzer, P.; Ertl, P. Applications of self-organizing neural networks in virtual screening and diversity selection. J. Chem. Inf. Model. 2006, 46, 2319-2323.
44. Wu, Z.; Yen, G.G. A SOM projection technique with the growing structure for visualizing high-dimensional data. Int. J. Neural Syst. 2003, 13, 353-365.
45. Furukawa, T. SOM of SOMs. Neural Netw. 2009, 22, 463-478.
46. Gupta, S.; Matthew, S.; Abreu, P.M.; Aires-de-Sousa, J. QSAR analysis of phenolic antioxidants using MOLMAP descriptors of local properties. Bioorg. Med. Chem. 2006, 14, 1199-1206.
47. Tetko, I.V. Associative neural network. Methods Mol. Biol. 2008, 458, 185-202.
48. Maniyar, D.M.; Nabney, I.T.; Williams, B.S.; Sewing, A. Data visualization during the early stages of drug discovery. J. Chem. Inf. Model. 2006, 46, 1806-1818.
49. Howe, T.J.; Mahieu, G.; Marichal, P.; Tabruyn, T.; Vugts, P. Data reduction and representation in drug discovery. Drug Discov. Today 2007, 12, 45-53.
50. Ivanenkov, Y.A.; Savchuk, N.P.; Ekins, S.; Balakin, K.V. Computational mapping tools for drug discovery. Drug Discov. Today 2009, 14, 767-775.
51. Moreau, G.; Broto, P. The autocorrelation of a topological structure: A new molecular descriptor. Nouv. J. Chim. 1980, 4, 359-360.
52. Bauknecht, H.; Zell, A.; Bayer, H.; Levi, P.; Wagener, M.; Sadowski, J.; Gasteiger, J. Locating biologically active compounds in medium-sized heterogeneous datasets by topological autocorrelation vectors: Dopamine and benzodiazepine agonists. J. Chem. Inf. Comput. Sci. 1996, 36, 1205-1213.
53. Hopkins, A.L.; Groom, C.R.; Alex, A. Ligand efficiency: A useful metric for lead selection. Drug Discov. Today 2004, 9, 430-431.
54. Miteva, M.A.; Violas, S.; Montes, M.; Gomez, D.; Tuffery, P.; Villoutreix, B.O. FAF-Drugs: Free ADME/tox filtering of compound collections. Nucleic Acids Res. 2006, 34, W738-W744.
55. Whitty, A. Growing PAINS in academic drug discovery. Future Med. Chem. 2011, 3, 797-801.
56. Baell, J.B.; Holloway, G.A. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J. Med. Chem. 2010, 53, 2719-2740.